{
    "clinical_study": {
        "@rank": "97574", 
        "arm_group": [
            {
                "arm_group_label": "Adalimumab", 
                "arm_group_type": "Active Comparator", 
                "description": "Induction period Maintenance period"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to demonstrate the efficacy and safety, and to assess the\n      pharmacokinetics of adalimumab administered subcutaneously (SC) in pediatric subjects with\n      moderate to severe ulcerative colitis (UC)."
        }, 
        "brief_title": "Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis", 
        "completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Ulcerative Colitis", 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative", 
                "Ulcer"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Ulcerative Colitis (UC) for at least 12 weeks prior to screening,\n             confirmed by endoscopy with biopsy.\n\n          -  Active ulcerative colitis with a Mayo Score of 6 - 12 points and endoscopy subscore\n             of 2 - 3 despite concurrent treatment with oral corticosteroids or immunosuppressants\n             or both.\n\n        Exclusion Criteria:\n\n          -  Subject with Crohn's disease (CD) or indeterminate colitis (IC).\n\n          -  Current diagnosis of fulminant colitis and/or toxic megacolon.\n\n          -  Subjects with disease limited to the rectum (ulcerative proctitis) during the\n             screening endoscopy.\n\n          -  Chronic recurring infections or active Tuberculosis (TB)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "225", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02065557", 
            "org_study_id": "M11-290", 
            "secondary_id": "2013-003032-77"
        }, 
        "intervention": [
            {
                "arm_group_label": "Adalimumab", 
                "description": "Subcutaneous (SC) injection", 
                "intervention_name": "Adalimumab", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antibodies, Monoclonal", 
                "Adalimumab"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "adalimumab", 
            "Ulcerative Colitis"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "link": {
            "url": "http://rxabbvie.com"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "Site Reference ID/Investigator# 120898"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120898", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota", 
                        "zip": "55905"
                    }, 
                    "name": "Site Reference ID/Investigator# 121056"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 121056", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Prague 5", 
                        "country": "Czech Republic", 
                        "zip": "15006"
                    }, 
                    "name": "Site Reference ID/Investigator# 122876"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 122876", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haifa", 
                        "country": "Israel", 
                        "zip": "31096"
                    }, 
                    "name": "Site Reference ID/Investigator# 120827"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120827", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Holon", 
                        "country": "Israel", 
                        "zip": "58100"
                    }, 
                    "name": "Site Reference ID/Investigator# 122435"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 122435", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel", 
                        "zip": "91031"
                    }, 
                    "name": "Site Reference ID/Investigator# 120830"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120830", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Banska Bystrica", 
                        "country": "Slovakia", 
                        "zip": "947 01"
                    }, 
                    "name": "Site Reference ID/Investigator# 120847"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120847", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bratislava", 
                        "country": "Slovakia", 
                        "zip": "83340"
                    }, 
                    "name": "Site Reference ID/Investigator# 120842"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120842", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Martin", 
                        "country": "Slovakia", 
                        "zip": "03601"
                    }, 
                    "name": "Site Reference ID/Investigator# 120844"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120844", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malaga", 
                        "country": "Spain", 
                        "zip": "29011"
                    }, 
                    "name": "Site Reference ID/Investigator# 121863"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 121863", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "11883"
                    }, 
                    "name": "Site Reference ID/Investigator# 121864"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 121864", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow, Strathclyde", 
                        "country": "United Kingdom", 
                        "zip": "G3 8SJ"
                    }, 
                    "name": "Site Reference ID/Investigator# 120864"
                }, 
                "investigator": {
                    "last_name": "Site Reference ID/Investigator# 120864", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Czech Republic", 
                "Israel", 
                "Slovakia", 
                "Spain", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis", 
        "overall_contact": {
            "email": "nattanan.reilly@abbvie.com", 
            "last_name": "Nattanan  Reilly", 
            "phone": "847-936-6225"
        }, 
        "overall_contact_backup": {
            "email": "debbie.tokimoto@abbvie.com", 
            "last_name": "Debbie  Tokimoto", 
            "phone": "847-938-9415"
        }, 
        "overall_official": {
            "affiliation": "AbbVie", 
            "last_name": "Roopal  Thakkar", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Canada: Health Canada", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Measured by Partial Mayo Score (PMS)", 
                "measure": "Proportion of subjects who achieve clinical remission", 
                "safety_issue": "No", 
                "time_frame": "Week 8"
            }, 
            {
                "description": "Measured by Mayo score", 
                "measure": "Proportion of subjects who responded at Week 8 per PMS and achieve clinical remission", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02065557"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measured by Mayo endoscopy subscore (defined as \u2264 1) in Week 8 responders per PMS", 
                "measure": "Proportion of subjects who achieve mucosal healing", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }, 
            {
                "description": "Measured by PUCAI remission (defined as < 10) in Week 8 responders per PMS", 
                "measure": "Proportion of subjects in Pediatric Ulcerative Colitis Activity Index (PUCAI) remission", 
                "safety_issue": "No", 
                "time_frame": "Week 52"
            }
        ], 
        "source": "AbbVie", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AbbVie", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}